Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies. - Wikidata - awgldk - TriplyDB

Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.

Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.

http://www.wikidata.org/entity/Q38046828

about

A global approach to HIV-1 vaccine development Novel directions in HIV-1 vaccines revealed from clinical trials Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs.A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS In silico Analysis of HIV-1 Env-gp120 Reveals Structural Bases for Viral Adaptation in Growth-Restrictive Cells.Natural infection as a blueprint for rational HIV vaccine design.Broadly neutralizing antibodies and the promise of universal vaccines: where are we now?Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis.Antibody-Mediated Therapy against HIV/AIDS: Where Are We Standing Now?

P2860

Q27024614-28B3A276-1A74-4542-8F8D-7D9F800390FE Q33645528-D69B26BA-3E24-433B-B725-B1141CE77F2E Q34548297-EF635788-624D-4147-968F-0D3F78400D1F Q35824686-1318BB2F-41FC-4F98-BDB8-CA1EB2E80C6C Q35925858-1024AA50-C5E5-4493-83FF-EA5D88740A8C Q36558933-B951B395-ECA6-4311-9A1F-E0810C5A6D40 Q37619134-78933BBC-28F5-4EBC-887A-B3AA2309154A Q38171571-B64A5D6D-32BD-4847-87E4-B1E6E7151454 Q38712684-3375B139-8B23-4859-928C-2EC799A5929B Q42248079-B1810067-1039-46EC-B457-8D745AF3D9C7 Q55436995-3DEC2372-3A87-4C29-8A03-D116824E2304

P2860

Role of human immunodeficiency virus type 1 envelope structure in the induction of broadly neutralizing antibodies.

http://www.wikidata.org/entity/Q38046828

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Role of human immunodeficiency ...... oadly neutralizing antibodies.

@en

type

label

Role of human immunodeficiency ...... oadly neutralizing antibodies.

@en

prefLabel

Role of human immunodeficiency ...... oadly neutralizing antibodies.

@en

P1433

Q38046828-4B17F7E2-2A25-4FF6-AEAD-77C2DAB1C662

P1476

Q38046828-B9121B47-7B44-4120-B719-1B94398F52B5

P2093

Q38046828-39B58A7F-005B-4A1C-A693-770F56C10541

Q38046828-F76BBBB4-8A2C-42AF-9F64-184B22405A08

Q38046828-F8EAA11D-52BE-4A92-A117-D27682041B3B

P2860

Q38046828-00623DD4-B23A-4771-BDD3-0148CC72E0EC

Q38046828-01C0B02A-BEE6-4903-A7A3-7894C4646D32

Q38046828-0A7129F0-93B0-4903-81C5-2D1215958FFB

Q38046828-0F1514C1-331D-4339-A57B-5D0ED2F11CDC

Q38046828-11A9FA6E-1FE3-4993-A0F6-B3F633A1E05A

Q38046828-122C1DBC-69A6-4467-9B51-23F837877730

Q38046828-134EF2E6-DD7E-4466-94C8-E8D923EB228D

Q38046828-15471640-A419-43CB-84BD-F7FED0B33FCD

Q38046828-15D60CC9-EE81-426D-8268-7760F5F0755D

Q38046828-166C03EF-656A-40CD-A552-19C3F5F16DFD

P304

Q38046828-161D3F85-F1BE-483E-9368-E29BE764A1AC

P31

Q38046828-4A7C0F61-EA83-4598-B472-9B110A26FDD8

P356

Q38046828-504DA6BE-8167-49D4-AA76-4B80E817BD2A

P407

Q38046828-DEAA6EA4-F3A6-4D54-A8C2-72B7C956E606

P433

Q38046828-E75C8E2A-162D-4BDB-8BA5-2AB887FBA5FA

P478

Q38046828-E9124E6D-AFCE-4577-ACE7-EB068ACFF74F

P50

Q38046828-2D7B3757-FDF9-4A78-988D-D0E0B52261BE

Q38046828-46920518-1FAC-4AF2-88CA-EF62F169A83A

P577

Q38046828-88390744-B9EC-4DFA-A62A-095599061D07

P698

Q38046828-694122F5-42A8-426E-B815-4F0189B115EF

P932

Q38046828-2698CEDF-E18B-40DA-8440-21FD42581169

P356

P1433

Journal of Virology

P1476

Role of human immunodeficiency ...... roadly neutralizing antibodies

@en

P2093

B Verrier

http://www.w3.org/2001/XMLSchema#string

C Genin

http://www.w3.org/2001/XMLSchema#string

P Lawrence

http://www.w3.org/2001/XMLSchema#string

P2860

Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ

Structural mechanism of trimeric HIV-1 envelope glycoprotein activation

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

Increasing the potency and breadth of an HIV antibody by using structure-based rational design

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

Structural definition of a conserved neutralization epitope on HIV-1 gp120

An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV

A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

P304

13152-13163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01110-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Fahd Benjelloun

P577

2012-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23015715

http://www.w3.org/2001/XMLSchema#string

P932

3503095

http://www.w3.org/2001/XMLSchema#string